Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (390)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1088
6.370
 Why?
Antirheumatic Agents
24
2024
278
5.830
 Why?
Veterans
32
2023
1397
4.190
 Why?
Spondylitis, Ankylosing
5
2020
46
2.520
 Why?
Hyperkalemia
3
2023
24
2.420
 Why?
Veterans Health
8
2023
175
2.230
 Why?
United States Department of Veterans Affairs
12
2021
633
2.040
 Why?
Methotrexate
10
2021
249
1.900
 Why?
Medication Adherence
7
2019
559
1.450
 Why?
Spondylarthritis
3
2020
45
1.340
 Why?
Natural Language Processing
4
2023
94
1.300
 Why?
Registries
18
2024
1873
1.300
 Why?
Rheumatology
2
2020
106
1.260
 Why?
Biological Products
6
2021
198
1.240
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
251
1.240
 Why?
Tumor Necrosis Factor-alpha
6
2024
1185
1.150
 Why?
Drug Substitution
3
2021
51
0.990
 Why?
Psoriasis
2
2015
85
0.920
 Why?
Aged
46
2024
21892
0.910
 Why?
Arthritis, Psoriatic
3
2019
20
0.860
 Why?
Lymphoma, Follicular
2
2021
38
0.860
 Why?
Sulfasalazine
3
2019
23
0.830
 Why?
Hydroxychloroquine
3
2019
55
0.800
 Why?
Misoprostol
1
2022
17
0.790
 Why?
HLA-B27 Antigen
3
2019
15
0.780
 Why?
Middle Aged
47
2024
30812
0.780
 Why?
Humans
96
2024
128019
0.780
 Why?
Lung Diseases, Interstitial
6
2024
592
0.770
 Why?
United States
31
2023
13785
0.740
 Why?
Databases, Factual
7
2018
1264
0.740
 Why?
Electronic Health Records
6
2023
973
0.730
 Why?
Cohort Studies
16
2024
5378
0.710
 Why?
Rituximab
2
2021
162
0.690
 Why?
Analgesics, Opioid
5
2020
886
0.690
 Why?
Infliximab
3
2016
100
0.680
 Why?
Practice Patterns, Physicians'
5
2019
1260
0.680
 Why?
Insurance Claim Review
2
2017
64
0.660
 Why?
Pharmaceutical Services
2
2019
81
0.650
 Why?
Buprenorphine
1
2023
160
0.640
 Why?
Algorithms
5
2020
1609
0.640
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
332
0.640
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
44
0.640
 Why?
Treatment Outcome
19
2024
10110
0.630
 Why?
Male
54
2024
62757
0.620
 Why?
Arthritis
2
2021
90
0.620
 Why?
Datasets as Topic
1
2019
109
0.610
 Why?
Anemia, Iron-Deficiency
1
2019
57
0.600
 Why?
Severity of Illness Index
12
2023
2703
0.600
 Why?
Antineoplastic Agents, Immunological
1
2020
175
0.590
 Why?
Etanercept
2
2016
56
0.590
 Why?
Adalimumab
2
2016
39
0.590
 Why?
Iron
2
2021
282
0.580
 Why?
Kidney Failure, Chronic
1
2022
540
0.550
 Why?
Renal Insufficiency, Chronic
2
2021
562
0.530
 Why?
Chronic Pain
3
2022
253
0.530
 Why?
Female
49
2024
68016
0.520
 Why?
Computer Simulation
4
2020
936
0.510
 Why?
Terminology as Topic
1
2017
199
0.500
 Why?
Opioid-Related Disorders
1
2023
480
0.490
 Why?
Delivery of Health Care
2
2022
888
0.490
 Why?
Diabetes Mellitus
3
2024
994
0.480
 Why?
Cross-Over Studies
1
2017
507
0.480
 Why?
Risk Factors
23
2024
9696
0.480
 Why?
Healthcare Common Procedure Coding System
1
2014
1
0.470
 Why?
Research Design
3
2020
1034
0.460
 Why?
Insurance, Pharmaceutical Services
2
2011
23
0.450
 Why?
Adipokines
3
2022
47
0.450
 Why?
Cytokines
5
2024
1984
0.440
 Why?
Models, Statistical
2
2017
621
0.430
 Why?
Narcotics
1
2013
45
0.430
 Why?
Ambulatory Care
2
2014
500
0.430
 Why?
Hospitalization
5
2021
2057
0.420
 Why?
Emergency Service, Hospital
3
2023
1896
0.400
 Why?
Comparative Effectiveness Research
1
2013
146
0.400
 Why?
Utah
7
2013
64
0.400
 Why?
Potassium
2
2023
139
0.400
 Why?
Drug Prescriptions
2
2013
245
0.390
 Why?
Remission Induction
3
2022
267
0.390
 Why?
Pharmaceutical Preparations
3
2022
168
0.380
 Why?
Time Factors
11
2021
6479
0.380
 Why?
Medicine
1
2013
117
0.380
 Why?
Decision Support Systems, Clinical
2
2012
205
0.370
 Why?
Drug Overdose
2
2012
319
0.370
 Why?
Health Services Accessibility
2
2019
895
0.370
 Why?
Proportional Hazards Models
8
2022
1194
0.370
 Why?
Carpal Bones
2
2021
14
0.360
 Why?
Inflammatory Bowel Diseases
1
2015
311
0.350
 Why?
Cardiovascular Diseases
8
2023
1994
0.350
 Why?
Disease Progression
2
2018
2598
0.350
 Why?
Retrospective Studies
18
2023
14404
0.340
 Why?
Practice Guidelines as Topic
2
2019
1482
0.330
 Why?
Potentially Inappropriate Medication List
2
2020
16
0.330
 Why?
Adiponectin
4
2024
234
0.330
 Why?
Quality Indicators, Health Care
1
2012
296
0.320
 Why?
C-Reactive Protein
4
2021
396
0.320
 Why?
Aged, 80 and over
13
2021
7029
0.310
 Why?
Risk Assessment
10
2021
3223
0.300
 Why?
Kaplan-Meier Estimate
3
2021
851
0.300
 Why?
Body Mass Index
6
2018
2260
0.300
 Why?
Incidence
9
2024
2614
0.290
 Why?
Antibodies, Monoclonal
1
2014
1354
0.290
 Why?
Prospective Studies
9
2024
7035
0.290
 Why?
Pneumonia, Bacterial
2
2020
111
0.280
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1272
0.280
 Why?
ROC Curve
3
2019
500
0.280
 Why?
International Classification of Diseases
4
2023
122
0.270
 Why?
Arthrodesis
3
2021
31
0.260
 Why?
Multimorbidity
2
2023
46
0.260
 Why?
Managed Care Programs
1
2007
133
0.250
 Why?
Predictive Value of Tests
4
2020
1934
0.250
 Why?
Propensity Score
3
2020
264
0.250
 Why?
Drug Utilization
2
2018
166
0.240
 Why?
Drug Therapy, Combination
2
2019
1012
0.240
 Why?
Patient Admission
1
2007
182
0.240
 Why?
Embryo, Nonmammalian
2
2005
167
0.230
 Why?
Adult
16
2022
35176
0.230
 Why?
Gene Targeting
1
2004
82
0.230
 Why?
Alarmins
1
2024
24
0.230
 Why?
Data Mining
3
2023
109
0.230
 Why?
Interleukin-33
1
2024
48
0.220
 Why?
Regression Analysis
3
2018
978
0.220
 Why?
Embryo, Mammalian
1
2004
226
0.220
 Why?
Wrist
2
2021
53
0.210
 Why?
Neoplasms
5
2023
2460
0.210
 Why?
Poisson Distribution
2
2017
73
0.210
 Why?
Wrist Joint
2
2021
63
0.210
 Why?
Follow-Up Studies
7
2021
4853
0.200
 Why?
Weight Loss
2
2018
725
0.200
 Why?
Stroke
2
2021
1063
0.200
 Why?
Diclofenac
1
2022
14
0.200
 Why?
Comorbidity
4
2023
1537
0.200
 Why?
Rheumatic Diseases
1
2023
69
0.200
 Why?
Blood Sedimentation
2
2019
34
0.200
 Why?
Chemokines
2
2021
221
0.200
 Why?
Research Report
1
2022
73
0.190
 Why?
Confidence Intervals
2
2016
316
0.190
 Why?
Polymerase Chain Reaction
1
2004
1020
0.190
 Why?
Genetic Testing
1
2004
428
0.190
 Why?
Linear Models
3
2018
816
0.180
 Why?
Waldenstrom Macroglobulinemia
1
2021
11
0.180
 Why?
Multivariate Analysis
5
2018
1492
0.180
 Why?
Hospitals, Veterans
3
2018
255
0.180
 Why?
Maintenance Chemotherapy
1
2020
22
0.180
 Why?
Prescription Drugs
2
2012
112
0.170
 Why?
Cyclophosphamide
2
2021
227
0.170
 Why?
Prosthesis-Related Infections
1
2021
73
0.170
 Why?
Arthritis, Infectious
1
2021
57
0.170
 Why?
Stem Cells
1
2004
577
0.170
 Why?
Pneumonia, Staphylococcal
1
2020
20
0.170
 Why?
SEER Program
1
2020
206
0.160
 Why?
Neoplasm Grading
1
2020
283
0.160
 Why?
Transferrin
1
2019
42
0.160
 Why?
Bipolar Disorder
1
2021
233
0.160
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
112
0.160
 Why?
Ferritins
1
2019
58
0.160
 Why?
Inappropriate Prescribing
1
2019
52
0.160
 Why?
Arthroplasty, Replacement, Hip
1
2021
135
0.150
 Why?
Ranolazine
1
2018
25
0.150
 Why?
Angina, Stable
1
2018
17
0.150
 Why?
Geriatrics
1
2019
80
0.150
 Why?
Drug Monitoring
2
2012
190
0.150
 Why?
Area Under Curve
1
2019
288
0.150
 Why?
Coronary Artery Disease
2
2022
675
0.150
 Why?
Osteoarthritis
1
2020
166
0.150
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
215
0.150
 Why?
Calcium Channel Blockers
1
2018
123
0.150
 Why?
Rheumatologists
1
2017
15
0.140
 Why?
Professional Practice Location
1
2017
29
0.140
 Why?
Heart Failure
2
2021
2141
0.140
 Why?
Brain Ischemia
1
2021
305
0.140
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
109
0.140
 Why?
Longitudinal Studies
4
2023
2706
0.140
 Why?
Random Allocation
1
2018
342
0.140
 Why?
Sacroiliitis
1
2017
6
0.140
 Why?
Reverse Transcriptase Inhibitors
1
2018
82
0.140
 Why?
Feasibility Studies
2
2020
860
0.140
 Why?
Communication
1
2023
838
0.140
 Why?
Obesity, Abdominal
1
2017
47
0.140
 Why?
Population Surveillance
2
2012
426
0.140
 Why?
Recovery of Function
1
2021
630
0.140
 Why?
Protease Inhibitors
1
2018
104
0.140
 Why?
Neoplasm Metastasis
1
2019
608
0.140
 Why?
Leptin
3
2022
218
0.140
 Why?
Bias
3
2013
196
0.140
 Why?
Data Accuracy
1
2017
57
0.140
 Why?
Disability Evaluation
1
2018
285
0.140
 Why?
Precision Medicine
1
2020
384
0.130
 Why?
HIV Integrase Inhibitors
1
2018
69
0.130
 Why?
Prognosis
3
2020
3766
0.130
 Why?
Travel
1
2017
121
0.130
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
73
0.130
 Why?
Risk Management
2
2007
85
0.130
 Why?
Neoplasm Staging
1
2020
1288
0.130
 Why?
Forecasting
1
2018
355
0.130
 Why?
Dose-Response Relationship, Radiation
1
2016
132
0.130
 Why?
Arthroplasty, Replacement, Knee
1
2021
300
0.130
 Why?
Anti-Inflammatory Agents
2
2018
467
0.130
 Why?
Pain
1
2022
748
0.130
 Why?
Antimicrobial Stewardship
1
2018
98
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
319
0.130
 Why?
Cross-Sectional Studies
6
2024
5034
0.130
 Why?
Hypertension
2
2018
1234
0.130
 Why?
Cyclosporine
1
2016
170
0.130
 Why?
Fees, Pharmaceutical
1
2015
10
0.130
 Why?
Drug Administration Routes
1
2015
37
0.120
 Why?
Observational Studies as Topic
1
2016
108
0.120
 Why?
Anti-Retroviral Agents
1
2018
230
0.120
 Why?
Anti-Infective Agents
1
2018
243
0.120
 Why?
Hospital Mortality
1
2020
844
0.120
 Why?
Cause of Death
4
2023
392
0.120
 Why?
Health Care Costs
1
2018
366
0.120
 Why?
Cross Infection
1
2017
199
0.120
 Why?
Logistic Models
2
2018
1975
0.120
 Why?
Pseudomonas Infections
1
2017
218
0.120
 Why?
Recombination, Genetic
3
2005
189
0.120
 Why?
Obesity
2
2018
2859
0.120
 Why?
Suicide
1
2021
577
0.120
 Why?
Inflammation Mediators
1
2017
495
0.110
 Why?
Drug Administration Schedule
1
2016
755
0.110
 Why?
Quality Improvement
1
2022
1093
0.110
 Why?
Glucocorticoids
1
2018
572
0.110
 Why?
Guideline Adherence
1
2018
523
0.110
 Why?
Health Expenditures
1
2015
179
0.110
 Why?
Infusions, Intravenous
1
2014
390
0.110
 Why?
Prednisone
3
2021
230
0.110
 Why?
Telemedicine
1
2022
781
0.110
 Why?
Causality
1
2013
115
0.100
 Why?
HIV Infections
2
2018
2703
0.100
 Why?
Integrases
3
2005
118
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
36
0.100
 Why?
Mortality
1
2015
306
0.100
 Why?
Adiposity
1
2017
504
0.100
 Why?
Socioeconomic Factors
2
2018
1211
0.100
 Why?
Pneumonia
1
2018
600
0.100
 Why?
Education, Medical, Continuing
1
2013
121
0.100
 Why?
Root Cause Analysis
1
2012
8
0.100
 Why?
Feedback
2
2023
159
0.100
 Why?
Prescription Drug Misuse
1
2012
39
0.100
 Why?
Florida
1
2012
92
0.100
 Why?
Occupational Injuries
1
2012
45
0.100
 Why?
Lung Diseases
1
2018
713
0.100
 Why?
Lung Neoplasms
2
2022
2327
0.100
 Why?
HIV-1
1
2018
833
0.090
 Why?
Health Personnel
1
2017
645
0.090
 Why?
Outpatients
1
2014
366
0.090
 Why?
Narration
1
2012
56
0.090
 Why?
Adolescent
5
2015
20158
0.090
 Why?
Internal Medicine
1
2013
246
0.090
 Why?
Antineoplastic Agents
1
2022
2041
0.090
 Why?
Osteoporotic Fractures
1
2012
57
0.090
 Why?
Risk
1
2013
850
0.090
 Why?
Reproducibility of Results
2
2016
3009
0.090
 Why?
Substance-Related Disorders
2
2023
1010
0.080
 Why?
Dose-Response Relationship, Drug
1
2014
1943
0.080
 Why?
Anti-Bacterial Agents
1
2020
1689
0.080
 Why?
Young Adult
3
2015
12281
0.080
 Why?
Blood Pressure
2
2018
1711
0.080
 Why?
Pattern Recognition, Automated
1
2008
72
0.070
 Why?
Sex Factors
3
2021
1942
0.070
 Why?
Catheter-Related Infections
1
2008
67
0.070
 Why?
Diagnosis, Computer-Assisted
1
2008
87
0.070
 Why?
Hospital Records
1
2007
11
0.070
 Why?
Cost Sharing
1
2007
14
0.070
 Why?
Financing, Personal
1
2007
26
0.070
 Why?
Referral and Consultation
1
2013
724
0.070
 Why?
Antihypertensive Agents
1
2011
481
0.070
 Why?
Biomarkers
3
2024
3874
0.070
 Why?
Nonlinear Dynamics
1
2007
88
0.070
 Why?
Machine Learning
2
2022
442
0.070
 Why?
Mutagenesis, Site-Directed
2
2005
358
0.070
 Why?
Insulin-Like Growth Factor I
2
1999
307
0.070
 Why?
Viral Proteins
2
1999
321
0.060
 Why?
Primary Health Care
2
2013
1639
0.060
 Why?
Artificial Intelligence
1
2008
244
0.060
 Why?
Drug Interactions
1
2007
361
0.060
 Why?
Respiratory Tract Diseases
2
2017
148
0.060
 Why?
Models, Theoretical
1
2008
541
0.060
 Why?
Blotting, Southern
1
2004
68
0.060
 Why?
Health Services Research
1
2007
389
0.060
 Why?
Chronic Disease
2
2022
1690
0.060
 Why?
Data Collection
1
2007
645
0.060
 Why?
Mental Disorders
1
2012
1005
0.060
 Why?
Mass Screening
1
2012
1145
0.060
 Why?
Myocardial Infarction
1
2011
1013
0.050
 Why?
Interleukin-17
1
2024
106
0.050
 Why?
Health Status
2
2018
747
0.050
 Why?
Vital Capacity
1
2023
289
0.050
 Why?
Acetazolamide
1
2022
24
0.050
 Why?
Odds Ratio
2
2018
1018
0.050
 Why?
Telomere Shortening
1
2022
19
0.050
 Why?
Medicare
1
2007
715
0.050
 Why?
Length of Stay
1
2007
1114
0.050
 Why?
Antimanic Agents
1
2021
18
0.050
 Why?
Lithium
1
2021
37
0.050
 Why?
Valproic Acid
1
2021
47
0.050
 Why?
Chlorambucil
1
2021
9
0.050
 Why?
Medication Therapy Management
1
2022
72
0.050
 Why?
Bendamustine Hydrochloride
1
2021
11
0.050
 Why?
Vidarabine
1
2021
30
0.050
 Why?
Patient Discharge
2
2023
850
0.050
 Why?
Bortezomib
1
2021
45
0.050
 Why?
Zebrafish
1
2005
464
0.040
 Why?
Pulmonologists
1
2020
15
0.040
 Why?
Cerebrovascular Circulation
1
2022
216
0.040
 Why?
Data Display
1
2020
20
0.040
 Why?
Vincristine
1
2021
109
0.040
 Why?
Quality Control
1
2020
156
0.040
 Why?
Computed Tomography Angiography
1
2021
115
0.040
 Why?
Magnetic Resonance Imaging
2
2022
3371
0.040
 Why?
Telomere
1
2022
226
0.040
 Why?
Pharmacists
1
2022
246
0.040
 Why?
User-Computer Interface
1
2020
147
0.040
 Why?
Range of Motion, Articular
1
2021
360
0.040
 Why?
Embryonic and Fetal Development
1
1999
92
0.040
 Why?
Bone Marrow Transplantation
1
2020
269
0.040
 Why?
Doxorubicin
1
2021
322
0.040
 Why?
Piperidines
1
2021
190
0.040
 Why?
Magnetic Resonance Angiography
1
2021
235
0.040
 Why?
Adenine
1
2021
255
0.040
 Why?
Dexamethasone
1
2021
339
0.040
 Why?
Patient Satisfaction
1
2022
624
0.040
 Why?
Time-to-Treatment
1
2019
178
0.040
 Why?
Gene Dosage
1
1998
142
0.040
 Why?
Cost-Benefit Analysis
1
2020
567
0.040
 Why?
Reoperation
1
2020
541
0.040
 Why?
Infant Mortality
1
1998
103
0.040
 Why?
Methicillin Resistance
1
2017
17
0.040
 Why?
Recurrence
1
2020
993
0.030
 Why?
Gene Expression Regulation, Developmental
2
1999
817
0.030
 Why?
HIV Integrase
1
2018
70
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Cardiovascular Agents
1
2018
152
0.030
 Why?
Absorptiometry, Photon
1
2017
248
0.030
 Why?
Critical Illness
1
2022
755
0.030
 Why?
Isoxazoles
1
2016
54
0.030
 Why?
Thinness
1
2016
89
0.030
 Why?
Nutrition Surveys
1
2017
261
0.030
 Why?
Body Weight
2
2016
930
0.030
 Why?
Viral Load
1
2018
449
0.030
 Why?
Rheumatoid Factor
1
2016
167
0.030
 Why?
Community-Acquired Infections
1
2017
153
0.030
 Why?
Lymphoma
1
2016
194
0.030
 Why?
Survival Analysis
1
2018
1262
0.030
 Why?
Analysis of Variance
1
2018
1266
0.030
 Why?
Peptides, Cyclic
1
2016
255
0.030
 Why?
Surveys and Questionnaires
2
2020
5353
0.030
 Why?
Leukemia
1
2016
228
0.030
 Why?
Quality of Health Care
1
2018
605
0.030
 Why?
Age Factors
1
2021
3100
0.030
 Why?
Life Style
1
2016
459
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2509
0.030
 Why?
Workers' Compensation
1
2012
26
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1558
0.020
 Why?
Inflammation
1
2022
2646
0.020
 Why?
Coroners and Medical Examiners
1
2011
7
0.020
 Why?
Death Certificates
1
2011
30
0.020
 Why?
Sampling Studies
1
2011
96
0.020
 Why?
Brain
1
2022
2615
0.020
 Why?
Smoking
1
2016
1459
0.020
 Why?
Prostatic Neoplasms
1
2016
1011
0.020
 Why?
Pancreatic Neoplasms
1
2016
873
0.020
 Why?
Medical Assistance
1
2007
10
0.020
 Why?
Quality of Life
1
2019
2672
0.020
 Why?
Models, Econometric
1
2007
33
0.020
 Why?
Psychoses, Substance-Induced
1
2007
14
0.020
 Why?
Deductibles and Coinsurance
1
2007
11
0.020
 Why?
Eligibility Determination
1
2007
63
0.020
 Why?
Child
1
2007
20636
0.020
 Why?
Inpatients
1
2011
464
0.020
 Why?
Evidence-Based Medicine
1
2011
709
0.020
 Why?
Costs and Cost Analysis
1
2007
200
0.020
 Why?
Delirium
1
2007
78
0.020
 Why?
Insurance Coverage
1
2007
219
0.020
 Why?
Blood Coagulation Disorders
1
2007
162
0.020
 Why?
beta-Galactosidase
1
2005
75
0.020
 Why?
HSP70 Heat-Shock Proteins
1
2005
67
0.010
 Why?
Mosaicism
1
2005
71
0.010
 Why?
Genes, Reporter
1
2005
265
0.010
 Why?
Animals, Genetically Modified
1
2005
231
0.010
 Why?
Sensitivity and Specificity
1
2008
1813
0.010
 Why?
Mice, Transgenic
2
1999
2066
0.010
 Why?
Case-Control Studies
1
2011
3324
0.010
 Why?
Hemorrhage
1
2007
643
0.010
 Why?
Recombinant Fusion Proteins
1
2005
634
0.010
 Why?
Liver
2
1999
1826
0.010
 Why?
Growth Disorders
1
1998
80
0.010
 Why?
Animals
3
2005
34487
0.010
 Why?
Mice
2
1999
16574
0.010
 Why?
RNA, Messenger
1
1998
2669
0.010
 Why?
Infant, Newborn
1
1998
5688
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (390) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)